We use cookies for certain features and to improve your experience. See our Cookie Policy and Privacy Policy to learn more

Leafly

Shop legal, local weed.

Open
advertise on Leafly
ShopDeliveryDispensariesDealsStrainsBrandsProductsCBDDoctorsCannabis 101Social impact
  • Sign in
  • Create account
  • Strains
  • Shop
  • Shop
  • Delivery
  • Deals
  • Dispensaries
  • CBD Stores
  • Brands
  • Products
  • Learn
  • Cannabis 101
  • News
  • Leafly Learn
  • Science of cannabis
  • Doctors
  • Social impact
  • Lab partners
  • Download the Leafly App
  • Advertise on Leafly
    • Leafly.comUSA flag
    • Leafly.caCanadian flag
  • Help
  1. Home
  2. News
  3. Politics
  4. Cannabis users’ right to work law advances in California
  • News
  • Cannabis 101
  • Growing
  • Strains & products
  • CBD
  • Politics
  • Health
  • Lifestyle
  • Science & tech
  • Industry
  • Reports
  • Canada
  • Podcasts
  • Leafly Lists
Politics

Cannabis users’ right to work law advances in California

David DownsLast updated September 1, 2022
Workers' rights takes a huge step forward if California bans unscientific marijuana testing this fall. (Image courtesy flickr/magnumppi)
(Flickr/magnumppi)

Thousands and thousands of California workers unjustly denied jobs or fired for unscientific marijuana tests could get new protections this Labor Day.

Assembly Bill 2188 passed out of the legislature on Aug. 30 and heads to Gov. Gavin Newsom’s desk for either signature or veto. If he signs the bill, workers’ rights takes a huge step forward across America.

AB 2188 makes it illegal for employers to discriminate against workers solely for off-duty weed use. It would also effectively end pre-employment urine testing, except for federal jobs and those in the building and construction trades.

Assemblymember Bill Quirk from Northern California, a former NASA climate scientist, sponsored the bill. He argues that urine testing workers for pot has no scientific merit. Consumer and patient groups like California NORML and Americans for Safe Access contend that it’s also an unjust giveaway to testing companies. The North American drug testing industry grossed nearly $2B in 2020, with projections estimating $4.5B in revenue by 2028. Leading company Quest Diagnostics performed 11 million screenings in 2021.

“It’s about time that the law kept up with science.”

-Matt Bell, Secretary-Treasurer, UFCW Local 324

“Not a single, scientifically controlled FDA study has shown cannabis metabolite testing to be effective in improving workplace safety or productivity,” California NORML states in a support letter.

A joint you smoked two weeks ago can get you fired when you report to work sober Monday. The Mayo Clinic confirms urine screens do not catch on-the-job impairment. In 2021, a California judge ruled the state could fire a CalTrans worker for a failed urine test. The judge reinstated the worker.

Testing is a cold war on drugs

Despite legalization in 2016, about one in ten employers in California still tests. About one in 20 of those tests comes back positive for pot. Critics say urine testing is part of an ongoing cold war on drugs that victimizes mainly low-income, low-skill workers in economically precarious retail and warehouse jobs. 

AB 2188 tells California employers, ‘Do better.’ Bosses would have to screen for active THC, not chemical remnants of the drug. 

In opposition statements to the legislature, the California Chamber of Commerce says there is “no way” to screen for active THC. They’re being disingenuous. Urinalysis is Reagan-era technology. In 2022, employers can test saliva or breath for active THC, or just give a coordination test on a smartphone or tablet. California’s unemployment rate sits at a record low 4.2%—businesses cannot afford to dismiss sober, responsible workers.

As Labor Day arrives, two big unions, the UFCW and SEIU, back the workers’ rights bill. Banning work discrimination for off-duty pot use has come up since 2008 in California, when then-Gov. Arnold Schwarzenegger vetoed State Sen. Mark Leno’s bill to do so. California once led the way with medical legalization in 1996 but has since fallen behind. Twenty-one states already have medical cannabis workers’ rights laws, and five states, including Illinois and New York, protect recreational consumers.

Related
The US cannabis industry now supports 428,059 jobs

“California has always led the nation in cannabis industry policies, and with AB 2188, we have the opportunity to lead once again by prohibiting discrimination against workers who legally consume cannabis when they are off the job,” stated Matt Bell, the Secretary-Treasurer of UFCW Local 324. “Using outdated cannabis tests only causes employees to feel unsafe and harassed at work, it does not increase workplace safety. UFCW members are proud to support AB 2188 because it’s about time that the law kept up with science.”

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries

Activists note that urine testing is a component of systemic classism and racism. The highest rate of drug screenings occurs in the Midwest and the South, and often target warehouse and other blue collar workers of color. In California, employers use urinalysis to avoid paying workman’s compensation for injuries. Workers who vape a delta-8 cartridge on Friday, then get injured while sober at work on Monday, may undergo urine screening to disallow benefits.

If the bill passes, California officials anticipate needing 19 full-time staff members to handle an estimated 500 cannabis discrimination complaints from workers per year.

Employer groups would prefer to retain the right to dismiss sober workers for now.

“I’m proud my union is sponsoring this important bill.”

—Jenny Phan, MedMen Long Beach employee, and a member of UFCW Local 324.

“If California policymakers wish to force a shift towards newer testing technologies—that is one thing…California employers should not have to fight out proper, impairment-based terminations,” the Chamber of Commerce states.

The UFCW states that it’s time for employers to evolve.

“AB 2188 … will start to turn the tide toward far more accurate, modern-day cannabis testing to detect recent use,” said Jenny Phan, an employee at cannabis dispensary MedMen Long Beach, and a member of UFCW Local 324. “I’m proud my union is sponsoring this important bill.”

Related
How to pass a drug test for weed–the ultimate guide

More work remains to be done. In California, AB 2188 does not address groups like probationers, parolees, seniors on opioids, and pregnant women and mothers—all of whom report THC discrimination by government agencies and healthcare providers. 

You can voice your opinion to Gov. Gavin Newsom on this bill, or the dozen other cannabis ones at this link. Politicians listen. Other state legislators can use the bill as model language for their state’s versions. 

Happy Labor Day, Leafly Nation.

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • Loading...
    Loading...Loading...
    Loading...
    Loading...Loading...
    Loading...Loading...
  • See all dispensaries
See all dispensaries
adult-use cannabisCaliforniapolitics
David Downs
David Downs
Leafly Senior Editor David Downs is the former Cannabis Editor of the San Francisco Chronicle. He's appeared on The Today Show, and written for Scientific American, The New York Times, WIRED, Rolling Stone, The Onion A/V Club, High Times, and many more outlets. He is a 2023 judge for The Emerald Cup, and has covered weed since 2009.
View David Downs's articles

The latest in Politics

  • How US import tariffs are impacting cannabis prices and products image
    How US import tariffs are impacting cannabis prices and products
    Leafly Staff
  • Ohioans must activate to defend cannabis freedoms from lawmakers image
    Ohioans must activate to defend cannabis freedoms from lawmakers
    David Downs
  • Montanans must activate to protect legalization in 2025 image
    Montanans must activate to protect legalization in 2025
    David Downs
  • Analysis: Don’t hold your breath for legalization under Trump 2.0 image
    Analysis: Don’t hold your breath for legalization under Trump 2.0
    David Downs
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

Something went wrong, please try again.

By providing us with your email address, you agree to Leafly’s Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App StoreDownload Leafly Marijuana Reviews on Google Play

Business Solutions
  • List your store
  • List your CBD store
  • List your brand
  • List your practice
  • Business log in

About Leafly
  • About us
  • Careers
  • Newsroom
  • Investor relations
  • Contact us
  • FAQs
  • Accessibility

Dispensaries in
  • Los Angeles
  • Seattle
  • Portland
  • San Francisco
  • Toronto
  • Detroit

Privacy & Terms
  • Terms of use
  • Commercial terms of use
  • Privacy policy
  • Do not sell my personal information

* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2025 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.